Literature DB >> 21986290

Hyperdiploidy associated with a high BCR-ABL transcript level may identify patients at risk of progression in chronic myeloid leukemia.

Fabio Stagno1, Paolo Vigneri, Maria Letizia Consoli, Alessandra Cupri, Stefania Stella, Loredana Tambè, Michele Massimino, Livia Manzella, Francesco Di Raimondo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21986290     DOI： 10.1159/000330607

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  8 in total

1.  Philadelphia-positive case negative for JAK2 V617F mutation with hyperdiploidic karyotype: A case report.

Authors:  Dragomira Nikolova; Vera Damyanova; Vasil Hrischev; Maria Markova; Lubomir Mitev; Aselina Asenova; Atanas Radinov; Draga Toncheva
Journal:  Mol Clin Oncol       Date:  2019-10-04

2.  Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib.

Authors:  Stefania Stella; Elena Tirró; Michele Massimino; Silvia Rita Vitale; Sabina Russo; Maria Stella Pennisi; Adriana Puma; Chiara Romano; Sandra DI Gregorio; Vanessa Innao; Fabio Stagno; Francesco DI Raimondo; Caterina Musolino; Livia Manzella
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

3.  Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.

Authors:  Michele Massimino; Stefania Stella; Elena Tirrò; Maria Letizia Consoli; Maria Stella Pennisi; Adriana Puma; Silvia Rita Vitale; Chiara Romano; Valentina Zammit; Fabio Stagno; Francesco Di Raimondo; Livia Manzella
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

4.  Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Faten Moassass; Adnan Ikhtiar; Thomas Liehr; Moneeb Abdullah Kassem Othman; Abdulsamad Wafa
Journal:  Mol Cytogenet       Date:  2014-11-29       Impact factor: 2.009

5.  Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.

Authors:  Stefania Stella; Valentina Zammit; Silvia Rita Vitale; Maria Stella Pennisi; Michele Massimino; Elena Tirrò; Stefano Forte; Antonio Spitaleri; Agostino Antolino; Sergio Siracusa; Vincenzo Accurso; Donato Mannina; Stefana Impera; Caterina Musolino; Sabina Russo; Alessandra Malato; Giuseppe Mineo; Maurizio Musso; Ferdinando Porretto; Bruno Martino; Francesco Di Raimondo; Livia Manzella; Paolo Vigneri; Fabio Stagno
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

6.  Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients.

Authors:  Chodimella Chandrasekhar; Pasupuleti Santhosh Kumar; Potukuchi Venkata Gurunadha Krishna Sarma
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

7.  Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report.

Authors:  Livia Manzella; Elena Tirrò; Silvia Rita Vitale; Adriana Puma; Maria Letizia Consoli; Loredana Tambè; Maria Stella Pennisi; Sandra DI Gregorio; Chiara Romano; Cristina Tomarchio; Francesco DI Raimondo; Fabio Stagno
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

8.  Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts.

Authors:  Michele Massimino; Elena Tirrò; Stefania Stella; Livia Manzella; Maria Stella Pennisi; Chiara Romano; Silvia Rita Vitale; Adriana Puma; Cristina Tomarchio; Sandra Di Gregorio; Agostino Antolino; Francesco Di Raimondo; Paolo Vigneri
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.